A detailed history of Rathbones Group PLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Rathbones Group PLC holds 14,000 shares of IPA stock, worth $4,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,000
Previous 14,000 -0.0%
Holding current value
$4,760
Previous $14,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$1.76 - $3.04 $24,640 - $42,560
14,000 New
14,000 $25,000

Others Institutions Holding IPA

About ImmunoPrecise Antibodies Ltd.


  • Ticker IPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,836,700
  • Market Cap $8.44M
  • Description
  • ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...
More about IPA
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.